ScreenerHero
VOXVoxel S.A.
GPW · PL · Healthcare · Diagnostics & Research · voxel.pl
133.80PLN+0.15%Mkt Cap: 355.36M $P/E: 3.57

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical tri…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap355.36M $
Enterprise Value402.64M $
Revenue (TTM)147.69M $
Gross Profit42.53M $
Net Income (TTM)24.95M $
Revenue/Share14.07 USD
Last Price133.80 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees356
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)3.57
P/E (Forward)14.03
PEG—
EV/EBITDA8.95
EV/Revenue2.73
P/S2.41
P/B3.66
EPS (TTM)37.47
EPS (Forward)—
52W Range
93.8047% of range179.00
52W High179.00 PLN
52W Low93.80 PLN
Profitability
Gross Margin28.77%
Oper. Margin27.04%
EBITDA Margin30.45%
Profit Margin16.88%
ROE24.10%
ROA13.94%
Growth
Revenue Growth-0.40%
Earnings Growth31.60%
Cash Flow & Leverage
Operating CF29.55M $
CapEx (TTM)19.20M $
FCF Margin1.24%
FCF Yield0.51%
Net Debt45.44M $
Net Debt/EBITDA1.01
Balance Sheet
Debt/Equity0.45
Current Ratio1.65
Quick Ratio1.32
Book Value/Sh36.57 PLN
Cash/Share1.614 PLN
Dividends
Fwd Div Rate2.500 PLN
Trail. Div Rate0.0000 PLN
Div. Yield1.95%
5Y Avg Yield—
Payout Ratio12.76%
Ex-Div DateSep 29, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)148.67 PLN
Upside (mean)+11.1%
Target Range141.10 PLN – 161.50 PLN
PLN141.10+11.1% to meanPLN161.50
# Analysts3
Ownership
Shares Out.10.50M
Float5.03M
Insiders37.43%
Institutions31.42%
Technical
SMA 50119.23 (+12.2%)
SMA 200122.50 (+9.2%)
Beta0.58
S&P 52W Chg18.16%
Avg Vol (30d)16.68K
Avg Vol (10d)8.01K
Technical Indicators
RSI (14)67.5
MACD3.5568
MACD Signal3.6703
MACD Hist.-0.1135
BB Upper134.03 PLN
BB Middle127.07 PLN
BB Lower120.11 PLN
BB Width10.96%
ATR (14)4.015 PLN
Vol Ratio (20d)0.51x